Clinical Trial Update: Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding [Phase 3]

View source ↗

Summary

This document reports Phase 3 trial results for a levonorgestrel-releasing intrauterine system (52 mg) used to treat heavy menstrual bleeding (menorrhagia), wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menorrhagia

Drugs mentioned

• Levonorgestrel-releasing intrauterine system (52 mg) (levonorgestrel intrauterine system)

Snippet

Sponsor: Medicines360 | Conditions: Menorrhagia | Phase 3 | Status: COMPLETED | Results posted: 2024-05-14